Picked up a bunch today! This is fantastic news, suprised the sp isn't skyrocketing today, I think the market doesn't understand the importance of the info in this NR. It's nuanced but it's there... changing endpoint cus their review showed success. This is F'n huge.
Remember they've looked at 200 hundred patients FINAL data...that's enough for statistical inference and Revive decides to submit for endpoint change. This isn't a whim or hope this is knowledge... without them clearly coming out with it yet until FDA reviewed.
A pill to prescribe to mild Covid cases...$$$$$$$. I see every doctor writing scripts for this, hospital, nursing home prophylactics in outbreaks.